Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Rain Therapeutics
Rain Therapeutics
Rain Targets Normal p53 Expression with Possible Pan-Cancer Therapeutic
BioSpace
Tue, 06/21/22 - 10:56 am
Rain Therapeutics
liposarcoma
clinical trials
pan-cancer
Rain Therapeutics headlines newest slate of IPO-bound biotechs with $100M penciled in for lead oncology program
Endpoints
Mon, 04/5/21 - 10:21 pm
IPOs
Rain Therapeutics
Impel NeuroPharma
Anebulo Pharmaceuticals
New targeted therapy approaches win Rain Therapeutics $63M — designed to beat a quick path to approval
Endpoints
Thu, 09/3/20 - 10:12 am
Rain Therapeutics
tarloxotinib
targeted drug delivery
Rain Therapeutics nets $18M to push lung cancer asset into phase 2
Fierce Biotech
Mon, 05/21/18 - 09:15 am
Rain Therapeutics
non-small cell lung cancer